by Biospring | Apr 26, 2022 | Biotech, Cell and Gene Therapy, Cell Therapy, CGT, Gene Therapy, Pharma
What if instead of treating the symptoms of a disease, we could target the source of the disease itself? Cell and Gene Therapy (C>) can do just that. These advanced therapies are the result of decades of research on the building blocks (cells) and blueprints...
by Biospring | Apr 25, 2022 | Abzena, Biologics, Biotech, CDMO, COVID-19, Drug Development, Drug Discovery, Drug Manufacturing, Pharma, Sven Lee
We shared an overview on Abzena following our investment in July. Over the past few months, Abzena has launched a new facility in San Diego and has made several executive hires. We recently spoke with Sven Lee, Chief Business Officer at Abzena, and he provided us with...
by Biospring | Apr 24, 2022 | Abzena, Biologics, Biotech, CDMO, Drug Development, Pharma
Over the past few months, the COVID-19 pandemic has revealed gaps in the global pharmaceutical supply chain for drugs in clinical trials and for marketed drugs. Drug manufacturing can be a long and complex process requiring specialized expertise. The biopharmaceutical...
